Author Interviews, Endocrinology, Epilepsy / 17.10.2017
Scientists Discover Why Seizures Are Harder To Control During Menstruation
MedicalResearch.com Interview with:
[caption id="attachment_21891" align="alignleft" width="125"]
Dr. Samba Reddy[/caption]
Dr. Samba Reddy, Ph.D., R.Ph., FAAPS, FAAAS, FAES
Professor
Neuroscience and Experimental Therapeutics
College of Medicine
Texas A&M University Health Science Center
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: For the past two decades, D. Samba Reddy, PhD, RPh, professor of neuroscience and experimental therapeutics at the Texas A&M College of Medicine, has been searching for answers to catamenial epilepsy, a subset of chronic epilepsy that causes a dramatic increase in seizures during women’s menstrual periods. Although this condition has been documented for millennia, there is currently no effective treatment for catamenial seizures, leaving many women and their families desperate for answers.
In this report, the researchers discovers the neuro-code for treating women with menstrual period-linked epilepsy. A unique platform has been created for clinical trials for catamenial seizures with synthetic neurosteroid agents.
Dr. Samba Reddy[/caption]
Dr. Samba Reddy, Ph.D., R.Ph., FAAPS, FAAAS, FAES
Professor
Neuroscience and Experimental Therapeutics
College of Medicine
Texas A&M University Health Science Center
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: For the past two decades, D. Samba Reddy, PhD, RPh, professor of neuroscience and experimental therapeutics at the Texas A&M College of Medicine, has been searching for answers to catamenial epilepsy, a subset of chronic epilepsy that causes a dramatic increase in seizures during women’s menstrual periods. Although this condition has been documented for millennia, there is currently no effective treatment for catamenial seizures, leaving many women and their families desperate for answers.
In this report, the researchers discovers the neuro-code for treating women with menstrual period-linked epilepsy. A unique platform has been created for clinical trials for catamenial seizures with synthetic neurosteroid agents.











